Inventiva (IVA) Receivables - Other (2018 - 2025)

Inventiva (IVA) posted quarterly Receivables - Other of $117568.4 for Q4 2025, up 96.47% year-over-year from $59841.3 in Q4 2024, and up 0.84% quarter-over-quarter from $116591.8 in Q2 2025.

Inventiva (IVA) Receivables - Other (2018 - 2025) Analysis & Trends

Inventiva's Receivables - Other history runs 8 years deep, the most recent figure standing at $117568.4 for Q4 2025.

  • In Q4 2025, Receivables - Other rose 96.47% year-over-year to $117568.4; the TTM figure through Dec 2025 stood at $117568.4 (up 96.47% YoY), while the FY2025 annual figure was $117568.4, up 96.47% from the prior year.
  • Receivables - Other for Q4 2025 stood at $117568.4, up from $116591.8 in the prior quarter.
  • The five-year high for Receivables - Other was $2.7 million in Q2 2024, with the low at $59841.3 in Q4 2024.
  • The 5-year median for Receivables - Other is $342627.5 (2021), against an average of $774628.2.
  • The sharpest annual moves came in 2023 and 2025: Receivables - Other soared 435.84% in 2023, then sank 95.7% in 2025.
  • Inventiva's Receivables - Other stood at $336327.5 in 2021, then slumped by 50.86% to $165280.1 in 2022, then soared by 183.18% to $468033.9 in 2023, then plunged by 87.21% to $59841.3 in 2024, then surged by 96.47% to $117568.4 in 2025.
  • Business Quant data shows IVA's Receivables - Other at $117568.4 in Q4 2025, $116591.8 in Q2 2025, and $59841.3 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Inventiva 888.89 Mn 888.89 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 117,568.39
Dec 31, 2025 117,568.39
Jun 30, 2025 116,591.85
Jun 30, 2025 116,591.85
Dec 31, 2024 59,841.34
Dec 31, 2024 59,841.34
Jun 30, 2024 2.71 Mn
Jun 30, 2024 2.71 Mn
Dec 31, 2023 468,033.86
Dec 31, 2023 468,033.86
Jun 30, 2023 1.87 Mn
Jun 30, 2023 1.87 Mn
Dec 31, 2022 165,280.07
Dec 31, 2022 165,280.07
Jun 30, 2022 348,927.54
Jun 30, 2022 348,927.54
Dec 31, 2021 336,327.46
Dec 31, 2021 336,327.46
Mar 31, 2021 1.55 Mn
Mar 31, 2021 1.55 Mn